8/6/2020 The Flower Mound team is awesome
During shortages of Wegovy, Ozempic, Mounjaro, and Zepbound, the FDA exercised temporary enforcement discretion , allowing compounding pharmacies to help meet patient demand. Once manufacturing stabilized: Semaglutide injection products were removed from the FDA Drug Shortage List Tirzepatide injection products were formally declared resolved Compounding reverted to pre-shortage federal and state limits Broad, shortage-based compounding is no longer allowed in 2026
Blood glucose levels must be maintained at all times to avoid hypoglycemia and to supply the brain with its preferential fuel
Using sharps containers and participating in community disposal programs can ensure that used needles are disposed of safely and responsibly
However, the absolute risk of this condition remains low among semaglutide users
Look out for these symptoms: Persistent feelings of sadness or hopelessness Loss of interest in activities once enjoyed Changes in appetite or sleep patterns Fatigue or loss of energy Difficulty concentrating or making decisions If you notice any of these signs, talk to your doctor right away
